Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Metro Supply Chain Group has acquired the Ontario warehousing and distribution operations of Van De Water-Raymond.
read more
Catalent Pharma Solutions and Valerius Biopharma announced that they are to collaborate on the development and manufacture of Valerius’ biosimilar products.
read more
Lodo Therapeutics Corporation has formed a strategic drug discovery collaboration with Genentech, a member of the Roche Group.
read more
Nutriband has signed an exclusive 20-year, $90 million distribution agreement for its transdermal consumer product lines with Best Choice.
read more
AGC Biologics has entered into a commercial supply agreement with MacroGenics for the manufacture of margetuximab, a clinical-stage, novel immune-optimized monoclonal antibody.
read more
PANTHERx has been selected by Otsuka distribute JYNARQUE, the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease.
read more
AMRI announces its new multipurpose aseptic API line at the company’s facility in Valladolid, Spain.
read more
Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division announces a 5 million Euro investment in their Cotia, Brazil facility.
read more
DURECT has entered into an amendment to the development and commercialization agreement with Sandoz, a division of Novartis, regarding POSIMIR in the United States.
read more
Alcami Corporation announces the advancement of the drug development process with the company’s new, dramatically-reduced analytical testing turnaround times.
read more
Takeda and Shire announced they have reached agreement on the terms of a recommended offer pursuant to which Takeda will acquire the entire share capital of Shire.
read more
Valeant Pharmaceuticals International, Inc. has announced that the company will change its name to Bausch Health Companies Inc., effective in July 2018.
read more
Ardena has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.
read more
Ascendia Pharmaceuticals has entered into a collaboration with KC Pharmaceuticals for the development of five OTC sterile ophthalmic drop medicines.
read more
STA Pharmaceutical announces that its API R&D and manufacturing facility located in Changzhou, China has secured Pre-Approval Inspection for two APIs from the FDA – with no Form 483s issued.
read more